CARIBOU BIOSCIENCES SHARES FALL 38% TO $0.70 AFTER THE BELL; ANNOUNCED DISCONTINUING CAR-T CELL THERAPY PROGRAMS, EVALUATING STRATEGIC ALTERNATIVES, SUBSTANTIAL JOB CUTS

Reuters · 2d ago

Please log in to view news